A path to precision in the ICU
暂无分享,去创建一个
David M. Maslove | Daren K. Heyland | John C. Marshall | J. Marshall | D. Heyland | D. Maslove | F. Lamontagne | Francois Lamontagne | J. Marshall
[1] Francesco Santini,et al. Mortality in Multicenter Critical Care Trials: An Analysis of Interventions With a Significant Effect* , 2015, Critical care medicine.
[2] Eirini Christaki,et al. The beginning of personalized medicine in sepsis: small steps to a bright future , 2014, Clinical genetics.
[3] A. Gemma,et al. F1000 highlights , 2010 .
[4] D. Cook,et al. Predicting Performance Status 1 Year After Critical Illness in Patients 80 Years or Older: Development of a Multivariable Clinical Prediction Model , 2016, Critical care medicine.
[5] Patrick R. Norris,et al. Personalized Medicine: Genetic Variation and Loss of Physiologic Complexity Are Associated With Mortality in 644 Trauma Patients , 2009, Annals of surgery.
[6] C. Hoggart,et al. Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children. , 2016, JAMA.
[7] I. Douglas,et al. Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis , 2012, The Pharmacogenomics Journal.
[8] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[9] Ralph B D'Agostino,et al. The randomized registry trial--the next disruptive technology in clinical research? , 2013, The New England journal of medicine.
[10] James F Burke,et al. Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care. , 2015, American journal of respiratory and critical care medicine.
[11] It's all in the genes: moving toward precision medicine in critical illness. , 2013, Critical care medicine.
[12] D. Maslove,et al. Brain Tissue Oxygenation in Patients with Septic Shock: a Feasibility Study , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[13] Simon C. Brewer,et al. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome , 2015, Intensive Care Medicine.
[14] Joon Lee,et al. Errors, Omissions, and Outliers in Hourly Vital Signs Measurements in Intensive Care , 2016, Critical care medicine.
[15] Vance G. Fowler,et al. Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients , 2014, PloS one.
[16] D. Maslove,et al. Identification of sepsis subtypes in critically ill adults using gene expression profiling , 2012, Critical Care.
[17] S. Opal,et al. The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?* , 2014, Critical care medicine.
[18] H. Hakonarson,et al. Genome Wide Association Identifies PPFIA1 as a Candidate Gene for Acute Lung Injury Risk Following Major Trauma , 2012, PloS one.
[19] V. Herasevich,et al. Sniffing out acute kidney injury in the ICU: do we have the tools? , 2013, Current opinion in critical care.
[20] H. Wong. Personalized medicine, endotypes, and intensive care medicine , 2015, Intensive Care Medicine.
[21] Christopher G. Chute,et al. BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..
[22] N. D. de Keizer,et al. Data Resource Profile: the Dutch National Intensive Care Evaluation (NICE) Registry of Admissions to Adult Intensive Care Units. , 2015, International journal of epidemiology.
[23] Rinaldo Bellomo,et al. Development and implementation of a high-quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. , 2006, Journal of critical care.
[24] Muin J. Khoury,et al. Will Precision Medicine Improve Population Health , 2017 .
[25] Kevin J. Tracey,et al. Sepsis definitions: time for change , 2013, The Lancet.
[26] C. Lindsell,et al. Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids* , 2016, Critical care medicine.
[27] J. Vincent. Individual gene expression and personalised medicine in sepsis. , 2016, The Lancet. Respiratory medicine.
[28] S. Opal,et al. Sepsis: a roadmap for future research. , 2015, The Lancet. Infectious diseases.
[29] Steve E. Calvano,et al. Continuous Enteral and Parenteral Feeding Each Reduces Heart Rate Variability But Differentially Influences Monocyte Gene Expression in Humans , 2012, Shock.
[30] M. Griffiths,et al. A stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive result , 2010, Critical care medicine.
[31] P. Andersen,et al. Genetic Influences on Incidence and Case-Fatality of Infectious Disease , 2010, PloS one.
[32] Derek C Angus,et al. Fusing Randomized Trials With Big Data: The Key to Self-learning Health Care Systems? , 2015, JAMA.
[33] Stuart A Scott,et al. Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing? , 2014, Pharmacogenomics.
[34] N. McCarthy,et al. Time to Change , 2017 .
[35] V. Herasevich,et al. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. , 2010, Mayo Clinic proceedings.
[36] J. Vincent. We should abandon randomized controlled trials in the intensive care unit , 2010, Critical care medicine.
[37] Timothy R Billiar,et al. Precision Medicine for Critical Illness and Injury , 2016, Critical care medicine.
[38] Robert J Freishtat,et al. BMC Medicine BioMed Central , 2009 .
[39] T. Nguyen,et al. Could Biomarkers Direct Therapy for the Septic Patient? , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[40] G. Bernard,et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. , 2014, Chest.
[41] R. Tompkins,et al. Development of a Genomic Metric That Can Be Rapidly Used to Predict Clinical Outcome in Severely Injured Trauma Patients* , 2013, Critical care medicine.
[42] Steven B. Johnson,et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels* , 2004, Critical care medicine.
[43] Kevin Delucchi,et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. , 2014, The Lancet. Respiratory medicine.
[44] D. Annane,et al. InFACT: a global critical care research response to H1N1 , 2010, The Lancet.
[45] Rajit K. Basu,et al. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray , 2011, Critical care.
[46] Carolyn R Rohrer Vitek,et al. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine. , 2016, Mayo Clinic proceedings.
[47] Subha Madhavan,et al. G-DOC Plus – an integrative bioinformatics platform for precision medicine , 2016, BMC Bioinformatics.
[48] J. Rello,et al. Septic shock in the era of precision medicine. , 2016, Journal of thoracic disease.
[49] Brahm Goldstein,et al. Heart rate variability in critical illness and critical care , 2002, Current opinion in critical care.
[50] A. Zanella,et al. Personalized medicine for ARDS: the 2035 research agenda , 2016, Intensive Care Medicine.
[51] M. Moasser,et al. The Evolving Landscape of HER2 Targeting in Breast Cancer. , 2015, JAMA oncology.
[52] OpenClinica D. Schrimpf,et al. Possible Combinations of Electronic Data Capture and Randomization Systems , 2014, Methods of Information in Medicine.
[53] S. Wesselingh,et al. Precision respiratory medicine and the microbiome. , 2016, The Lancet. Respiratory medicine.
[54] P. Andersen,et al. Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.
[55] R. Dickson. The microbiome and critical illness. , 2016, The Lancet. Respiratory medicine.
[56] D. Heyland,et al. Failure to engage hospitalized elderly patients and their families in advance care planning. , 2013, JAMA internal medicine.
[57] Christopher W Seymour,et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[58] J. Witte,et al. Association of common genetic variation in the protein C pathway genes with clinical outcomes in acute respiratory distress syndrome , 2016, Critical Care.
[59] Purvesh Khatri,et al. A comprehensive time-course–based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set , 2015, Science Translational Medicine.
[60] G. Bernard,et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome , 2013, Critical Care.
[61] J. Russell. Genomics and pharmacogenomics of sepsis: so close and yet so far , 2016, Critical Care.
[62] Derek C Angus,et al. Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design. , 2016, American journal of respiratory and critical care medicine.
[63] Vipul Kashyap,et al. The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside , 2011, J. Biomed. Semant..
[64] Joseph Loscalzo,et al. Precision medicine in cardiology , 2016, Nature Reviews Cardiology.
[65] Andrew James,et al. Big Data in the Intensive Care Unit , 2017, AMIA.
[66] B. Shen,et al. The Clinical Utility of Precision Medicine: Properly Assessing the Value of Emerging Diagnostic Tests , 2010, Clinical pharmacology and therapeutics.
[67] Peter Szolovits,et al. MIMIC-III, a freely accessible critical care database , 2016, Scientific Data.
[68] S. Galli,et al. Toward precision medicine and health: Opportunities and challenges in allergic diseases. , 2016, The Journal of allergy and clinical immunology.
[69] D Schrimpf,et al. Possible combinations of electronic data capture and randomization systems. principles and the realization with RANDI2 and OpenClinica. , 2014, Methods of information in medicine.
[70] M. Reilly,et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome , 2014, Science Translational Medicine.
[71] Stephanie Devaney,et al. A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment , 2016, PloS one.
[72] David J. Stone,et al. "Big data" in the intensive care unit. Closing the data loop. , 2013, American journal of respiratory and critical care medicine.
[73] J. Marshall. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[74] K. Famous,et al. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy , 2016, American journal of respiratory and critical care medicine.
[75] Anna Rautanen,et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.
[76] Vitaly Herasevich,et al. Enrollment into a time sensitive clinical study in the critical care setting: results from computerized septic shock sniffer implementation , 2011, J. Am. Medical Informatics Assoc..
[77] J. Connor,et al. The platform trial: an efficient strategy for evaluating multiple treatments. , 2015, JAMA.